38 research outputs found

    Solar Energy: Incentives to Promote PV in EU27

    Get PDF
    The growth in the use of renewable energies in the EU has been remarkable. Among these energies is PV. The average annual growth rate for the EU-27 countries in installed PV capacity in the period 2005-2012 was 41.2%. While the installed capacity of PV has reached almost 82 % of National Renewable Energy Action Plan (NREAP) targets for the EU-27 countries for 2020, it is still far from being used at its full potential. Over recent years, several measures have been adopted in the EU to enhance and promote PV. This paper undertakes a complete review of the state of PV power in Europe and the measures taken to date to promote it in EU-27. 25 countries have adopted measures to promote PV. The most widespread measure to promote PV use is Feed- in Tariffs. Tariffs are normally adjusted, in a decreasing manner, annually. Nevertheless, currently, seven countries have decided to accelerate this decrease rate in view of cost reduction of the installations and of higher efficiencies. The second instrument used to promote PV in the EU-27 countries is the concession of subsidies. Nevertheless, subsidies have the disadvantage of being closely linked to budgetary resources and therefore to budgetary constraints. In most EU countries, subsidies for renewable energy for PV are being lowered. Twelve EU-27 countries adopted tax measures. Low-interest loans and green certificate systems were only sparingly used

    Modelling the transmission dynamics of Theileria annulata : model structure and validation for the Turkish context

    Get PDF
    A mathematical model that describes the transmission dynamics of Theileria annulata is proposed that consists of 2 host components: the Hyalomma tick population and a compartmental model of T. annulata infection in the cattle population. The model was parameterized using data describing tick infestation and the infection status of cattle in Turkey from 2006 to 2008. The tick attachment rates are highly seasonal and because of the temporal separation of infectious and susceptible ticks virtually all ticks are infected by carrier cattle, so that annual peaks of disease in cattle do not impact on infection in the Hyalomma tick population. The impact of intervention measures that target the tick population both on the host and in the environment and their impact on the transmission of T. annulata were investigated. Interventions that have a limited ‘one-off’ impact and interventions that have a more permanent impact were both considered. The results from the model show the importance of targeting ticks during the period when they have left their first host as nymphs but have yet to feed on their second host

    Prévalence de la pneumopathie à Pneumocystis Jiroveci au cours des déficits immunitaires héréditaires observés en Tunisie

    No full text
    International audiencePneumocystis Jiroveci pneumonia (PJP) is a rare opportunistic infection in immunodeficient patients in Tunisia, as well as in other Africain countries including those with a high prevalence of AIDS. In the literature, PJP has been reported in primary immunodeficiency diseases (PID) namely SCID T–B– or T–B+ or X-linked hyper-IgM syndrome.ObjectiveTo evaluate the prevalence of PJP in the different PID observed in Tunisia.Patients and methodsThis retrospective study concerned 290 cases of PID confirmed by immunological investigation including the study of specific and/or non-pecific humoral and cellular immunity. The identification of P. Jiroveci in patients suspected of pneumocystosis was achieved by parasitological investigation in bronchoalveolar lavages.ResultsA PID associated to a parasitologically confirmed pneumocystic infection was found in 9 out of 290 patients (3%) among whom the majority (7 patients) had an HLA class II combined immunodeficiency. The latter is an autosomic recessive disease which has been reported mainly in North African families. Indeed, this population is characterized by a high rate of consanguinity. Interestingly, no PJP has been observed neither in SCID T–B– or T–B+ nor in X-linked hyper-IgM syndrome.Discussion and conclusionPJP seems to be particularly frequent in HLA class II deficiency patients, since 7 out of 22 patients with this deficiency had a PJP (31%). Due to this defect, antigen presenting cells are unable to present the antigen to T lymphocytes demonstrating the critical role of CD4+ T lymphocytes responses in the immune response to this pathogen.La pneumopathie Ă  Pneumocystis Jiroveci (PPJ) est une infection opportuniste peu frĂ©quente dans notre pays, ainsi que dans d'autres pays africains incluant ceux avec une prĂ©valence Ă©levĂ©e du sida. Dans la littĂ©rature, la PPJ a Ă©galement Ă©tĂ© rapportĂ©e au cours des dĂ©ficits immunitaires hĂ©rĂ©ditaires (DIH) notamment les SCID T–B– ou T–B+ et le syndrome d'hyper-IgM dans sa forme liĂ©e Ă  l'X.ObjectifÉvaluer la prĂ©valence de la PPJ au cours des diffĂ©rents types de DIH observĂ©s en Tunisie.Patients et mĂ©thodesUne Ă©tude rĂ©trospective a concernĂ© 290 cas de DIH confirmĂ©s par l'exploration de l'immunitĂ© cellulaire et humorale, spĂ©cifique et non spĂ©cifique. La recherche de P. Jiroveci sur liquide de lavage bronchoalvĂ©olaire a Ă©tĂ© effectuĂ©e chez les malades suspects de pneumocystose.RĂ©sultatsUne association entre DIH et une infection Ă  P. Jiroveci, confirmĂ©e parasitologiquement, a Ă©tĂ© retrouvĂ©e chez 9 sur 290 patients (3 %) parmi lesquels une majoritĂ© (7) Ă©tait atteinte d'un dĂ©ficit immunitaire combinĂ© par dĂ©faut d'expression des molĂ©cules HLA de classe II (DIC HLA II-). Il s'agit d'une affection autosomique rĂ©cessive particuliĂšrement frĂ©quente dans la population maghrĂ©bine qui est caractĂ©risĂ©e par un taux Ă©levĂ© de consanguinitĂ©. Aucune PPJ associĂ©e Ă  un SCID T–B– ou T–B+ ou Ă  un syndrome d'hyper-IgM liĂ© Ă  l'X n'a Ă©tĂ© observĂ©e.Discussion et conclusionLa PPJ est donc particuliĂšrement frĂ©quente au cours du DIC HLA II- puisqu'elle est retrouvĂ©e dans 7 sur 22 cas diagnostiquĂ©s avec ce dĂ©ficit (31 %). Par ailleurs, ces rĂ©sultats observĂ©s chez des enfants dont les cellules prĂ©sentatrices sont incapables de prĂ©senter l'antigĂšne aux lymphocytes T par dĂ©faut d'expression des molĂ©cules HLA de classe II confirment le rĂŽle critique des rĂ©ponses T CD4+ dans la rĂ©ponse immune contre ce pathogĂšne

    Toxoplasma gondii infection and toxoplasmosis in North Africa: A review

    No full text
    International audienceToxoplasmosis is an important zoonosis caused by an obligate intracellular parasitic protozoan, Toxoplasma gondii. The disease is distributed worldwide and can affect all warm-blooded vertebrates, including humans. The present review aimed to collect, compile and summarize the data on the prevalence of T. gondii infection in humans and animals in the five North African countries (Morocco, Algeria, Tunisia, Libya and Egypt). Published data from national and international databases were used. Distribution patterns and risk factors for T. gondii infection are discussed, focusing on biotic and abiotic factors. This review is a comprehensive epidemiological analysis of T. gondii infection in North Africa and will therefore be a useful tool for researchers. It can also be used to propose or enhance appropriate national toxoplasmosis control programs.La toxoplasmose est une zoonose importante causĂ©e par un protozoaire parasite intracellulaire obligatoire, Toxoplasma gondii. La maladie est rĂ©pandue dans le monde entier, chez tous les vertĂ©brĂ©s Ă  sang chaud, y compris les humains. La prĂ©sente Ă©tude visait Ă  collecter, compiler et rĂ©sumer les donnĂ©es sur la prĂ©valence de l’infection par T. gondii chez l’homme et les animaux dans les cinq pays d’Afrique du Nord (Maroc, AlgĂ©rie, Tunisie, Libye et Égypte). Les donnĂ©es publiĂ©es dans des bases de donnĂ©es nationales et internationales ont Ă©tĂ© utilisĂ©es. Les schĂ©mas de distribution et les facteurs de risque d’infection par T. gondii sont discutĂ©s, en se concentrant sur les facteurs biotiques et abiotiques. Cette synthĂšse est une analyse Ă©pidĂ©miologique complĂšte de l’infection par T. gondii en Afrique du Nord et sera donc un outil intĂ©ressant pour les chercheurs. Elle peut Ă©galement ĂȘtre utilisĂ©e pour proposer ou renforcer des programmes nationaux appropriĂ©s de contrĂŽle de la toxoplasmose
    corecore